TechnologyNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1397183IVDA stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $6.5M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

IVDA Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Iveda Solutions, Inc. (IVDA), a Technology sector company. IVDA is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $6.5m in revenue. Based on the latest XBRL financial filings (Q1 2026), Iveda Solutions, Inc. reports quarterly revenue of $1.5M, net income of $-532.8K, free cash flow of $-927.1K. Top institutional holders of IVDA by reported 13-F value include GEODE CAPITAL MANAGEMENT,, CITADEL ADVISORS, VANGUARD FIDUCIARY CO, based on the most recent SEC filings. IVDA trades on the Nasdaq exchange and files with the SEC under CIK 1397183. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IVDA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Iveda Solutions, Inc. directly from SEC EDGAR.

Revenue

Q1 2026

$1.5M

Net Income

Q1 2026

$-532.8K

Free Cash Flow

Q1 2026

$-927.1K

D/E Ratio

Q1 2026

0.06

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-18.7% YoY
$5.3MFY 2025
FY21 $1.9MFY22 $4.5MFY23 $6.5MFY25 $5.3M

Net Income

+22.8% YoY
$-3.2MFY 2025
FY21 $-3.0MFY22 $-3.3MFY23 $-4.1MFY25 $-3.2M

Operating Income

+20.1% YoY
$-3.2MFY 2025
FY21 $-2.7MFY22 $-3.3MFY23 $-4.0MFY25 $-3.2M

EPS (Diluted)

+57.5% YoY
$-0.44FY 2025
FY21 FY22 $-0.26FY23 $-1.03FY25 $-0.44

Total Assets

-11.5% YoY
$6.4MFY 2025
FY21 $3.0MFY22 $9.9MFY23 $7.3MFY25 $6.4M

Total Debt

+95.1% YoY
$680.5KFY 2025
FY21 $509.1KFY22 $654.6KFY23 $348.8KFY25 $680.5K

Op. Cash Flow

+39.2% YoY
$-2.0MFY 2025
FY21 $-2.0MFY22 $-5.4MFY23 $-3.3MFY25 $-2.0M

AI Insight: IVDA Financial Trends

Iveda remains unprofitable with stagnant $1–2M quarterly revenue and persistent operating losses; no clear path to profitability visible.

Revenue has contracted to $1M in Q4 2025 and Q1 2026, down from $2M average in 2024, signaling demand weakness.

Operating cash flow has improved to breakeven ($0M) in Q3 2025 and Q4 2025, compared to persistent -$1M burn in prior quarters.

Net losses remain volatile, ranging -$0M to -$2M quarterly; no quarterly profitability achieved in 8-quarter window.

Equity grew from nil to $6M by Q1 2026 (likely capital injection); debt stable at $1M masks deteriorating operating performance.

Operating income has not improved above -$0M since Q3 2025; sustained $1–2M revenue base insufficient to support fixed costs.

AI Insight: IVDA Ratio Trends

Iveda reversed Q3 2025 momentum: operating margin deteriorated to -37.9% in Q1 2026, erasing six-quarter improvement trend.

Operating margin collapsed from -13.0% in Q3 2025 to -37.9% in Q1 2026, reversing consistent sequential recovery.

Net profit margin followed suit, sliding from -13.4% to -35.7% quarter-over-quarter, indicating broad profitability deterioration.

ROA worsened to -27.1% in Q1 2026 from -15.3% in Q3 2025, signaling sharply reduced asset efficiency.

Q1 2026 reversal breaks eight-quarter improvement arc; Q3 2025 was closest point to profitability (-13% OpMargin).

Leverage inched up: D/E ratio moved from 0.09 to 0.14 by Q4 2025, though latest TTM shows reversion to 0.09.

Get alerted when IVDA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Iveda Solutions, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of IVDA

Put IVDA on your watchlist

Track score changes the day Iveda Solutions, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is IVDA a good stock to buy?

13F Pro's AI-powered analysis of Iveda Solutions, Inc. (IVDA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for IVDA are available on the IVDA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own IVDA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling IVDA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Iveda Solutions, Inc.'s investment landscape.